(Q35114106)

6 August 2017

1 reference

title

The expanding role of pathologists in the diagnosis and management of breast cancer: Worldwide Excellence in Breast Pathology Program (English)

1 reference

6 August 2017

The Expanding Role of Pathologists in the Diagnosis and Management of Breast Cancer: Worldwide Excellence in Breast Pathology Program (English)

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

27 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

27 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

27 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

27 December 2023

1

Shahla Masood

1 reference

6 August 2017

author name string

Worldwide Excellence in Breast Pathology Program

2

1 reference

6 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12713504

27 December 2023

publication date

1 May 2003

1 reference

full work available at URL

6 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1524-4741.9.s2.11.x

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1524-4741.9.s2.11.x/fullpdf

27 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

27 December 2023

1 reference

6 August 2017

volume

9 Suppl 2

1 reference

6 August 2017

page(s)

S94-7

1 reference

Nondiagnostic stereotaxic core breast biopsy: results of rebiopsy

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.11.X

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.11.X

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.11.X

Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.11.X

The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.11.X

Metastasis-suppressor genes: a review and perspective on an emerging field

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.11.X

STI571: a paradigm of new agents for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.11.X

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1524-4741.9.S2.11.X

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

27 December 2023

4

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Sentinel lymphadenectomy in breast cancer

27 December 2023

5

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology

27 December 2023

7

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

27 December 2023

8

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors.

27 December 2023

11

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

27 December 2023

15

56

518

Singletary SE

2000

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Cytologic differentiation between proliferative and nonproliferative breast disease in mammographically guided fine-needle aspirates

27 December 2023

17

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Prognostic and diagnostic implications of estrogen and progesterone receptor assays in cytology

27 December 2023

18

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Prognostic factors in breast cancer: use of cytologic preparations

27 December 2023

19

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Pharmacogenomics: a clinician's primer on emerging technologies for improved patient care

27 December 2023

22

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Transcriptional profiling in cancer: the path to clinical pharmacogenomics.

27 December 2023

24

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

The advent of targeted therapeutics and implications for pathologists

27 December 2023

25

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

27 December 2023

26

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Borderline Epithelial Lesions of the Breast

27 December 2023

28

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria

27 December 2023

29

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Reproducibility and validity of pathologic classifications of benign breast disease and implications for clinical applications

27 December 2023

30

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Can FNA biopsy separate atypical hyperplasia, carcinoma in situ, and invasive carcinoma of the breast?: Cytomorphologic criteria and limitations in diagnosis

27 December 2023

32

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831

27 December 2023

34

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message

27 December 2023

35

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Journal of cellular biochemistry. Supplement

27 December 2023

37

18

28

Masood S

1994

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

Fine-needle aspiration of breast cancer. Relationship of clinical factors to cytology results in 689 primary malignancies

27 December 2023

40

1 reference

https://api.crossref.org/works/10.1046/J.1524-4741.9.S2.11.X

27 December 2023

Identifiers

1 reference

6 August 2017

1 reference